Streetbeat News

Regulatory

ONDS

Ondas Holdings Inc. (NASDAQ:ONDS) announced that its subsidiary Airobotics has signed an annual service agreement for the ongoing maintenance of the Optimus Systems operated by a local government entity in Dubai, UAE. The Optimus Systems, part of an urban drone infrastructure solution, have been extensively utilized for public safety and emergency response applications. Airobotics expects the Optimus Urban Drone Infrastructure to be widely deployed across Dubai and grow to more than 20 systems over the next few years.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:32 pm

SPY

The USA Nonfarm Payrolls for June came in at 209K, lower than the estimated 225K and significantly lower than the previous month's 306K.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:30 pm

BABA

GRRR

LEVI

Gorilla Technology (GRRR) shares are up after signing a $270 million contract with the Egyptian Government. Alibaba (BABA) stock is rising amid reports of China ending its regulatory overhaul on Ant Group with a penalty of at least $1.1 billion. Levi Strauss & Co (LEVI) shares are down after reporting a Q2 margin decline and issuing soft FY23 EPS guidance, along with an 18% inventory increase.

Portfolio Pulse from ryanfaloona@benzinga.com

July 07, 2023 | 12:25 pm

BABA

FXI

China's authorities have fined Ant Group 7.1 billion yuan and ordered the company to cease operations of Xianghubao and compensate its consumers. The authorities also stated that most issues with the financial platforms have been rectified.

Portfolio Pulse from Charles Gross

July 07, 2023 | 12:12 pm

BWV

Blue Water Biotech, Inc. (NASDAQ:BWV) has received regulatory approval from the Ohio State Board of Pharmacy to operate as a pharmaceutical wholesaler. The company has recently acquired multiple FDA-approved pharmaceutical assets and announced an asset purchase agreement with WraSer, LLC and Xspire Pharma, LLC. BWV shares are trading higher by 4.50% to $1.16 in the premarket session.

Portfolio Pulse from Nabaparna Bhattacharya

July 07, 2023 | 12:09 pm

ACST

Acasti Pharma Inc. (NASDAQ:ACST) has announced a 1-for-6 reverse stock split to regain compliance with the NASDAQ Capital Market's $1.00 minimum bid price continued listing requirement. The split will reduce the number of outstanding common shares from approximately 44.6 million to about 7.4 million and will become effective on July 10, 2023.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:03 pm

JZXN

Jiuzi Holdings plans to execute a 1-for-18 reverse share split to regain compliance with the minimum bid price requirement of $1.00 per ordinary share for continued listing on Nasdaq. The split-adjusted trading is expected to begin on or around July 10, 2023.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 12:03 pm

ESPR

Esperion (NASDAQ:ESPR) will present additional data from the CLEAR Outcomes study on cardiovascular disease (CVD) prevention at the 2023 American Society for Preventive Cardiology Congress. The presentation will focus on the use of ezetimibe among participants in the trial.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:03 pm

ZVSA

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) has been granted a patent by the European Patent Office for its Phase 2a-ready Cholesterol Efflux Mediator VAR 200 for use in diabetic nephropathy/diabetic kidney disease. This development could potentially strengthen ZyVersa's position in the biopharmaceutical market.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 11:39 am

FXI

China is considering increasing local bond sales to help pay off its risky hidden debt, according to Bloomberg. This move could potentially impact the iShares China Large-Cap ETF (FXI), which tracks large Chinese companies.

Portfolio Pulse from Charles Gross

July 07, 2023 | 11:34 am